Anthogyr joins Straumann for its “implantation" in international markets

  • Home - EN
  • NEWS
  • Anthogyr joins Straumann for its “implantation" in international markets
With their know-how and their innovation capabilities, this alliance offers the two structures the possibilities of both technological and commercial synergies.

Anthogyr joins Straumann for its “implantation" in international markets

Published on 26 April 2016
Anthogyr and Straumann, two major players in dental implantology, recently concluded a partnership for the development of both actors in international markets. This partnership based on Straumann acquiring up to 30% in the capital of Anthogyr, will enable them to benefit from the distribution branch, Instradent, of the Straumann Group platform and to conquer the rapidly expanding market for dental implants in China.

Anthogyr designs, manufactures and distributes a full range of implants and instruments to help professionals of dental health to treat millions of patients around the world. Located in Sallanches, the company employs over 400 people and achieved a turnover of 45 M€ in 2015. For several years, Anthogyr has been supported in its financial plans by Bpifrance investment.

The Swiss group Straumann, one of the leaders in implant dentistry, offers its products and services to dental professionals as well as laboratories in more than 70 countries. The company currently employs over 2,400 people.

LAMY LEXEL, with Jean-Pierre GITENAY, partner, Magalie RÉVILLON-PERSAT, associate director counsel, and Antoni THEL, lawyer from the "Corporate, Merger and Acquisition, Stock Exchange, Finance” department, intervened in this operation as an advisor to Bpifrance Investissement, one of the outbound investors.

Contact us

Would you like more information on LAMY LEXEL or make an appointment ? Help us to give you the answer best adapted to your situation by filling in this form and we will answer you as soon as possible.
SUBSCRIBE TO OUR NEWSLETTERS ON LEGAL NEWS